These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 3470787

  • 1. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.
    Shapiro R, Vallee BL.
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2238-41. PubMed ID: 3470787
    [Abstract] [Full Text] [Related]

  • 2. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.
    Lee FS, Shapiro R, Vallee BL.
    Biochemistry; 1989 Jan 10; 28(1):225-30. PubMed ID: 2706246
    [Abstract] [Full Text] [Related]

  • 3. Human angiogenin, an organogenic protein.
    Riordan JF, Vallee BL.
    Br J Cancer; 1988 Jun 10; 57(6):587-90. PubMed ID: 2457389
    [Abstract] [Full Text] [Related]

  • 4. Interaction of human placental ribonuclease with placental ribonuclease inhibitor.
    Shapiro R, Vallee BL.
    Biochemistry; 1991 Feb 26; 30(8):2246-55. PubMed ID: 1998683
    [Abstract] [Full Text] [Related]

  • 5. Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay.
    Bond MD, Vallee BL.
    Biochemistry; 1988 Aug 23; 27(17):6282-7. PubMed ID: 3064806
    [Abstract] [Full Text] [Related]

  • 6. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes.
    St Clair DK, Rybak SM, Riordan JF, Vallee BL.
    Proc Natl Acad Sci U S A; 1987 Dec 23; 84(23):8330-4. PubMed ID: 3479795
    [Abstract] [Full Text] [Related]

  • 7. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.
    Shapiro R, Vallee BL.
    Biochemistry; 1989 Sep 05; 28(18):7401-8. PubMed ID: 2479414
    [Abstract] [Full Text] [Related]

  • 8. Tryptophan fluorescence as a probe of placental ribonuclease inhibitor binding to angiogenin.
    Lee FS, Auld DS, Vallee BL.
    Biochemistry; 1989 Jan 10; 28(1):219-24. PubMed ID: 2706245
    [Abstract] [Full Text] [Related]

  • 9. Characterization of ribonucleolytic activity of angiogenin towards tRNA.
    Lee FS, Vallee BL.
    Biochem Biophys Res Commun; 1989 May 30; 161(1):121-6. PubMed ID: 2730651
    [Abstract] [Full Text] [Related]

  • 10. Expression of human placental ribonuclease inhibitor in Escherichia coli.
    Lee FS, Vallee BL.
    Biochem Biophys Res Commun; 1989 Apr 14; 160(1):115-20. PubMed ID: 2653313
    [Abstract] [Full Text] [Related]

  • 11. Binding of placental ribonuclease inhibitor to the active site of angiogenin.
    Lee FS, Vallee BL.
    Biochemistry; 1989 Apr 18; 28(8):3556-61. PubMed ID: 2742853
    [Abstract] [Full Text] [Related]

  • 12. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
    Lee FS, Vallee BL.
    Biochemistry; 1990 Jul 17; 29(28):6633-8. PubMed ID: 2397204
    [Abstract] [Full Text] [Related]

  • 13. An in vitro binding assay for angiogenin using placental ribonuclease inhibitor.
    Bond MD.
    Anal Biochem; 1988 Aug 15; 173(1):166-73. PubMed ID: 3189795
    [Abstract] [Full Text] [Related]

  • 14. Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogenin.
    Harper JW, Vallee BL.
    Proc Natl Acad Sci U S A; 1988 Oct 15; 85(19):7139-43. PubMed ID: 2459697
    [Abstract] [Full Text] [Related]

  • 15. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of 40S ribosomes.
    St Clair DK, Rybak SM, Riordan JF, Vallee BL.
    Biochemistry; 1988 Sep 20; 27(19):7263-8. PubMed ID: 3207674
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro studies of angiogenin--a potent angiogenic factor.
    Badet J, Soncin F, N'Guyen T, Barritault D.
    Blood Coagul Fibrinolysis; 1990 Dec 20; 1(6):721-4. PubMed ID: 1723310
    [Abstract] [Full Text] [Related]

  • 17. A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis.
    Harper JW, Vallee BL.
    Biochemistry; 1989 Feb 21; 28(4):1875-84. PubMed ID: 2719939
    [Abstract] [Full Text] [Related]

  • 18. C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin.
    Rybak SM, Auld DS, St Clair DK, Yao QZ, Fett JW.
    Biochem Biophys Res Commun; 1989 Jul 14; 162(1):535-43. PubMed ID: 2473749
    [Abstract] [Full Text] [Related]

  • 19. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
    Newton DL, Xue Y, Olson KA, Fett JW, Rybak SM.
    Biochemistry; 1996 Jan 16; 35(2):545-53. PubMed ID: 8555226
    [Abstract] [Full Text] [Related]

  • 20. Dual site model for the organogenic activity of angiogenin.
    Hallahan TW, Shapiro R, Vallee BL.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2222-6. PubMed ID: 2006161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.